The Washington Post @washingtonpost
The “unusual” collaboration unfolded through at least 115 meetings, calls and email exchanges between the company and the FDA in a year, said the report released Thursday by the Committees on Oversight and Reform, and Energy and Commerce. https://t.co/7nvmPC8xOk — PolitiTweet.org